Document Detail

The β-Ketoacyl-ACP Synthase from Mycobacterium tuberculosis as Potential Drug Targets.
MedLine Citation:
PMID:  21370994     Owner:  NLM     Status:  Publisher    
The continuous preventive measures and control of tuberculosis are often hampered by re-emergence of multi-drug-resistant (MDR) strains of Mycobacterium tuberculosis. A novel drug approach is desperately needed to combat the global threat posed by MDR strains. In spite of current advancement in biological techniques viz. microarray and proteomics data for tuberculosis, no such potent drug has been developed in the past decades yet. Therefore, mycolic acid is an essential constituent which is involved in the formation of cell wall of Mycobacterium species. The biosynthesis of mycolic acid is involved in two fatty acid synthase systems, the multifunctional polypeptide fatty acid synthase I (FASI) which performs de novo fatty acid synthesis and dissociate FASII system. FASII system consists of monofunctional enzymes and acyl carrier protein (ACP), elongating FASI products to long chain mycolic acid precursor. In this review, the β-ketoacyl-ACP synthases (fadH, kasA and kasB) are distinct and play a vital role in mycolic acid synthesis, cell wall synthesis, biofilm formation and also pathogenesis. On the basis of substantial observation we suggest that these enzymes may be used as promising and attractive targets for novel anti-TB drugs designing and discovery.
V Singh; I Mani; D K Chaudhary; P Somvanshi
Related Documents :
18793624 - Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet-b radiation-induced ...
7104514 - Effect of lipid peroxidation on p-aminohippurate transport by rat kidney cortical slices.
2153484 - Rapid enzymatic analysis of plasma for tyrosine.
21261834 - Poly-3-hydroxyalkanoate synthases from pseudomonas putida u: substrate specificity and ...
18959994 - Analysis of peracetic acid solutions.
12953204 - (s,s)-2,3-dihydroxy-2,3-dihydrobenzoic acid: microbial access with engineered cells of ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-2
Journal Detail:
Title:  Current medicinal chemistry     Volume:  -     ISSN:  1875-533X     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9440157     Medline TA:  Curr Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Bioinformatics Centre, Biotech Park, Sector-G, Jankipuram, Kursi Road, Lucknow-226021, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Influence of the insertion time and number of polyps on miss rate in colonoscopy.
Next Document:  Expression of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibits the Processing of uMtCK to Induce Cell D...